Name: Rapport Therapeutics, Inc. Common Stock (RAPP) Earnings Call
Start: 2026-11-05

Recent quarters

Latest 2 quarters

Beat in 1 of 2 · beat then fell 0 · average move ⁦±4.2%⁩

Quarter	EPSReported / estimate	RevenueReported / estimate	Reaction
Q2 FY2026 2026-08-05	-1.19 / -0.96 -23.6%	— / $2.22M	+0.57% ⁦+0.77⁩ pts vs SPY
Q1 FY2026 2026-05-07	-0.42 / -0.56 +25.0%	$20.0M / $7.50M +166.7%	+7.74% ⁦+8.05⁩ pts vs SPY

Reported / estimate

Q2 FY2026 · 2026-08-05+0.57%
EPS-1.19 / -0.96-23.6%
Revenue— / $2.22M
Q1 FY2026 · 2026-05-07+7.74%
EPS-0.42 / -0.56+25.0%
Revenue$20.0M / $7.50M+166.7%

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.

Next report

2026-11-05

In 9 daysQ3 FY2026BMO· Expected date

83 days ago

⁦-23.6%⁩EPS Miss

2026-08-05Q2 FY2026BMO

⁦+0.57%⁩

⁦+0.77⁩ pts vs SPY

Session ⁦2026-08-05⁩